Kensei Yamaguchi

To evaluate the efficacy of MRgFUS treatment of adenomyosis over a 2-year follow-up, symptom severity, alternative treatment and adverse events were examined. Thirty-nine women (mean age 40.9 years), with symptomatic adenomyosis who had com…